RXFP1 [relaxin-1] receptors identified by receptor autoradiography are widely distributed in the brain localized to discrete regions of the olfactory system, neocortex, hypothalamus, hippocampus, thalamus, amygdala, midbrain, and medulla. High levels of RXFP1 binding in the subfornical organ (SFO) ["responsive to a wide variety of hormones and neurotransmitters"], organum vasculosum of the lamina terminalis (OVLT), and the paraventricular and supraoptic hypothalamic nuclei (400, 404, 515) provide the anatomical and biochemical basis for the control of plasma osmolality by relaxin.

[...]

Relaxin is a potent chronotropic and inotropic agent in the rat heart (271, 290, 417, 418) and also has inotropic effects on the human heart (127) (see sect. VIIA). It produces its effects by acting directly on RXFP1 receptors located mainly in the atria.

[...]
The first studies on the expression of RXFP3 mRNA in human tissues indicated very low expression of RXFP3 mRNA in the adrenal gland, testis, salivary gland, and pancreas by RT-PCR. Subsequent studies demonstrated RXFP3 [relaxin-3] mRNA expression in the human testis by RT-PCR (314), although the function of the receptor in this tissue is not known.
https://www.physiology.org/doi/full/...rev.00001.2012

Relaxin has been shown to reduce cardiac fibrosis in animal models by inhibiting cardiac fibroblasts secreting collagen and stimulating matrix metalloproteinase.

Relaxin receptors have been found in the heart, smooth muscle, the connective tissue, and central [" (relaxin-3) is predominantly localized in the brain and locally affects selected regions of the CNS, such as those responsible for the sense of appetite and stress regulation"] and autonomous nervous system
Neuropeptides such as relaxin-3 are attracting increasing interest as targets for the pharmacological treatment of a range of neuropsychiatric diseases. Due to the ability of relaxin-3 to modulate neuronal processes/behaviours such as mood, stress responses and cognition, which are often aberrant in mental illnesses, considerable potential exists for the development of relaxin-3-based drugs to therapeutically treat depression and other mental illnesses
In males, relaxin enhances motility of sperm in semen. In the male, it is produced in the prostate and is present in human semen
https://en.wikipedia.org/wiki/Relaxin
https://en.wikipedia.org/wiki/Relaxin-3

"We conclude that male and/or female relaxin may be important in activating the uterine cytokine/chemokine network required to initiate maternal immune adaptation to pregnancy."

"...presence of the specific relaxin receptor, RXFP1, also suggest the possibility that relaxin may be additionally present on spermatozoa"

"The initial ejaculate comprises largely epididymal fluid ("relaxin is a product mostly of the epididymis") containing sperm and some testicular contribution, together with some secretion from the prostate and preputial glands (Rodríguez-Martínez et al., 2011). This is followed by increasing amounts of prostatic and seminal vesicle fluid, which together alter the physical properties of the ejaculate."
https://www.frontiersin.org/articles...017.00422/full

Translation: Dick juice cures all your mind ailments, lmfao.

Men (no homo) and women (no thoto), forget about them pesky school shooter-generating SSRIs, just have some Dick* lol. You know what they say: "Dick in the morning, in the afternoon, and in the evening keeps the coffin maker away. "

According to the above data, the "initial ejaculate" is the most potent Depression-Be-Gone™️ portion of the Potion so don't forget to spit out the rest because FUCK the p*triarchy and FUCK m*n.** (Translated even more: Quit that debate shit, boiiii, and have sex, incels. ;)

**(Top 10 content creator lifehacks how to make your wholesome Christian family blog Pozzense Adsense-friendly.)



down the rabbit hole ('abandon hope all ye who enter here'):
Spoiler!